维普期刊资源整合服务平台（V6.5）

49篇 您的检索式：作者名="Sullivan NJ"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Interleukin-6 induces an epithelial mesenchymal transition phenotype in human breast cancer cells显示文摘	Sullivan NJ Sasser AK Axel AE	2009	Oncogene2009，28，：	1
2	Interleukin-6 induces an epi- thelial-mesenchymal transition phenotype in human breast cancer cells 显示文摘	Sullivan NJ Sasser AK Axel AE	2009	Oneogene2009，28，33：	1
3	Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells显示文摘	Sullivan NJ Sasser AK Axel AE	2009	Oncogene2009，28，33：	1
4	A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial 显示文摘	Martin JE Sullivan NJ Enama ME	2006	Clin Vaccine Immunol2006，13，11：	1
5	Development of a preventive vaccine for Ebola virus infection in primates显示文摘	Sullivan NJ Sanchez A Rollin PE	2000	Nature2000，408，6812：	1
6	Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cellcytotoxicityandinjury显示文摘	Yang ZY Duckers HJ Sullivan NJ	2000	Nat Med2000，6，：	1
7	Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast canc- er ceils 显示文摘	Sullivan NJ Sasser AK Axel AE	2009	Oncogene2009，28，33：	1
8	Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury显示文摘	Yang ZY Duckers HI Sullivan NJ	2000	Nat Med2000，6，：	1
9	The neutrophil alloantigen HNA-3a(5b)is located on choline transporter-like protein 2 and appears to be encoded by an R > Q154 amino acid substitution 显示文摘	Curtis BR Cox NJ Sullivan MJ	2010	Blood2010，115，10：	1
10	Interleukin-6 in- duces an epithelial mesenchymal transition phenotype in human breast cancer cells 显示文摘	Sullivan NJ Sasser AK Axel AE	2009	Oncogene2009，28，33：	1
11	Correlates of protective immunity for Ebola vaccines : implications for regulatory approval by the animal rule 显示文摘	Sullivan NJ Martin JE Graham BS	2009	Nat Rev Microbiol2009，7，：	1
12	Recombinant adenovirus serotype 26(Ad26)and Ad35vaccine vectors bypass immunity to Ad5and protect nonhuman primates against ebolavirus challenge显示文摘	Geisbert T W Bailey M Hensley Asiedu C Geisbert J Stanley D Honko A Johnson J Mulangu S Pau MG Custers J Vellinga J Hendriks J Jahrling P Roederer M Goudsmit J Koup R Sullivan NJ	2011	J Virol2011，85，9：	1
13	Immunopathology of highly virulent pathogens: insights from Ebola virus显示文摘	Zampieri CA Sullivan NJ Nabel GJ	2007	Nat lmmunol2007，8，11：	1
14	A DNA vaccine for Ebola virus is safe and immunogenic in a phase \| clinical trial 显示文摘	Martin JE Sullivan NJ Enama ME	2006	Clin Vaccine Immunol2006，13，11：	1
15	A DNA vaccine for Ebola virus is safe and immunogenic in a phase Ⅰ clinical trial 显示文摘	Martin JE Sullivan NJ Enama ME	2006	Clin Vaccine Immunol2006，13，11：	1
16	Immunopathology of highly virulent pathogens: insights from Ebola virus 显示文摘	Zampieri CA Sullivan NJ Nabel GJ	2007	Nat Immunol2007，8，11：	1
17	Correlates of protective immunity for Ebola vaccines:implications for regulatory approval by the animal rule显示文摘	Sullivan NJ Martin JE Graham BS	2009	Nat Rev Microbiol2009，7，5：	1
18	A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial 显示文摘	Martin JE Sullivan NJ Enama ME	2006	Clin Vaccine Immunol2006，13，11：	1
19	A DNA vaccine for E- bola virus is safe and immunogenic in a phase I clinical trial显示文摘	Martin JE Sullivan NJ Enama ME et d	2006	Clin Vaccine Immunol2006，13，11：	1
20	Antibody-mediated enhancement of viral disease显示文摘	Sullivan NJ	2001	Curr Top Microbiol Immunol2001，260，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示